The results provide strong evidence that AMPK-KLF10 axis repressed the expression of SREBP-1C by binding to its promoter and subsequently downregulated lipogenesis, whereas KLF10 deficiency enhanced NAFLD. This evidence concerns the gene KLF10 and metabolic dysfunction-associated steatotic liver disease.